Denmark· DK-28103443702
Fuzeon
A enfuvirtide product containing enfuvirtid, registered in Denmark by Roche Registration GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Enfuvirtide is registered in 10 of 19 countries.
Countries holding a registration under ATC J05AX07 (enfuvirtide), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Enfuvirtide · ATC J05AX07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ENFUVIRTID
- Manufacturer
- Roche Registration GmbH
- Country
- Denmark (DK)
- ATC code
- J05AX07
- ATC class
- Enfuvirtide
- Defined daily dose
- 0.18 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103443702
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for enfuvirtide.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Enfuvirtide · interactions on record
2 records
- 2 moderate
Most severe, free to view
- Darunavir and cobicistatJ05AR14moderate
- CobicistatV03AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AX07
Enfuvirtide, as other registers publish it.
- IrelandFuzeonRoche Registration GmbH
- FinlandFuzeonRoche Registration GmbH
- PolandFuzeonRoche Registration GmbH
- IcelandFuzeonRoche Registration GmbH*
- CzechiaFUZEONRoche Registration GmbH, Grenzach-Wyhlen
- United KingdomFuzeon 108mg powder and solvent for solution for injection vialsRoche Products Ltd
- BelgiumFuzeon 90 mg/mlRoche Registration
- BelgiumFuzeon 90 mg/mlRoche Registration
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af3707d3-fa14-4b6d-8dd1-38101cfeb170 GET /v1/drugs/af3707d3-fa14-4b6d-8dd1-38101cfeb170?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "90 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28103443702",
"substance": "ENFUVIRTID",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "37768"
}See everything about enfuvirtide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.